Crystal Bales
Payments from drug & device makers
Across 161 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$371
- AbbVie$365
- AstraZeneca$297
- Lilly USA, LLC$278
- Pfizer$260
- Amgen$216
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,888100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $371 |
| AbbVie | 19 | $365 |
| AstraZeneca | 17 | $297 |
| Lilly USA, LLC | 17 | $278 |
| Pfizer | 12 | $260 |
| Amgen | 16 | $216 |
| Boehringer Ingelheim | 11 | $200 |
| Astellas Pharma US Inc | 9 | $162 |
| GSK | 8 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Neurocrine Biosciences, Inc. | 3 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $78 |
| Shield Therapeutics Inc | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Urovant Sciences Inc | 2 | $39 |
| Merck | 2 | $32 |
| Bayer | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Abbott | 1 | $17 |
| Medtronic | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,888 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 76 | $114,371 |
| OzempicSemaglutide | 55 | $107,133 |
| EliquisApixaban | 46 | $57,097 |
| FarxigaDapagliflozin Propanediol | 53 | $41,924 |
| TrulicityDulaglutide | 30 | $38,925 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $28,512 |
| LinzessLinaclotide | 26 | $26,464 |
| MyrbetriqMirabegron | 35 | $24,930 |
| Nurtec OdtRimegepant Sulfate | 18 | $22,585 |
| EntrestoSacubitril/Valsartan | 14 | $15,677 |
| Spiriva RespimatTiotropium Bromide | 18 | $13,578 |
| GemtesaVibegron | 15 | $10,296 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $6,684 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $5,984 |
| Gabapentin | 216 | $3,009 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $278 | $153,295106 claims |
| Novo NordiskOzempic | $371 | $107,13355 claims |
| PfizerEliquis, Nurtec Odt | $260 | $79,68164 claims |
| AstraZenecaFarxiga | $297 | $41,92453 claims |
| GSKTrelegy Ellipta | $125 | $28,51220 claims |
| AbbVieLinzess, Synthroid | $365 | $28,15646 claims |
| Astellas Pharma US IncMyrbetriq | $162 | $24,93035 claims |
| Boehringer IngelheimSpiriva Respimat | $200 | $13,57818 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $40 | $10,29615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Macon
- Villanueva SpiveyMacon$18K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.